Genenta Science S p a (GNTA) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access GNTA Annual Income Statement →
By examining income statement figures across successive periods, users can identify shifts in Genenta Science S p a's profitability and expense structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Q4 2025
0 0 0 (Dec 31 2024)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing4.37
Research and Development Expense3.02
Other Operating Expense / -Income0.00
Total operating costs including COS7.40
Operating income / -loss-7.40
Net Interest (-)Expense / Income0.00
Foreign Currency Transaction Gain (Loss), Unrealized-0.61
Other loss / -income0.53
Total costs & expenses7.31
Income & Taxes
Income / -loss before income taxes-7.31
Income after income taxes-7.31
Income / -loss from continuing operations-7.31
Net income / -loss-7.31
Income / -loss to shareholder-7.31
EBIT-7.31
EBITD-7.28
EBITDA-7.28
Earnings Per Share
Basic EPS (excl. extra items)-0.37
Basic Net EPS-0.37
Diluted Net EPS-0.37
4 historic quarters locked

Sign in to unlock the full Genenta Science S p a income statement history.

About GNTA Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.